UpdatesPress Release
Alivus Life Sciences acquired 76% of IQGenX Pharma for INR 9.12 Cr.
Alivus Life Sciences LimitedALIVUS · Filed with the exchange
This expands Alivus's capabilities into advanced formulation development, integrating an end-to-end platform.
It boosts CDMO services and leverages API expertise for global market access and strategic asset out-licensing.
No comments yet. Be the first.